| Original Articles |
|
Analysis of Treatment Pattern in COPD Patients Using Health Insurance Claims Data: Focusing on Inhaled Medications
|
| Hana Lim and Mihai Park |
| Korean J Clin Pharm 2022;32(3):155-165 |
|
|
|
The Effect of Regulation on Recruitment Advertising for Clinical Trial Subjects in Korea
|
| Hyun Jin Kim and Hyun Soon Sohn |
| Korean J Clin Pharm 2022;32(3):166-177 |
|
|
|
Medication Prescribing Status in Pediatric Patients with Migraine
|
| Kiyon Rhew |
| Korean J Clin Pharm 2022;32(3):178-184 |
|
|
|
Evaluation of Clinical Outcomes by Therapeutic Dosing Interval of Denosumab (Prolia®) and Calcium-Vitamin D Prescriptions
|
| Youkyeong Kim, Junghyun Kim, Hyunjeong Doh, Young Mi Jeong, Jeonghwa Lee, Ju-Yeun Lee, and Euni Lee |
| Korean J Clin Pharm 2022;32(3):185-190 |
|
|
|
Assessing the Effectiveness and Safety of Direct-acting Antiviral Treatment in Korean Patients with Hepatitis C Virus Genotype 1b or 2 at a Tertiary Care Hospital
|
| Mi Seon Park, Young-Mo Yang, Ki Hyun Park, Hyonok Yoon, Ju Sin Kim, and Eun Joo Choi |
| Korean J Clin Pharm 2022;32(3):191-203 |
|
|
|
Real-world Adverse Events Associated with Fluconazole and Itraconazole: Analysis of Nationwide Data Using a Spontaneous Reporting System Database
|
| Yu gyeong Lee, Jungmin Lee, and Pusoon Chun |
| Korean J Clin Pharm 2022;32(3):204-214 |
|
|
|
Cost Avoidance and Clinical Pharmacist Interventions on Hospitalized Patients in Hematologic malignancies
|
| Ye Seul Kim, So Yeon Hong, Yoon Hee Kim, Kyung Suk Choi, Jeong Hwa Lee, Ju-Yeun Lee, and Euni Lee |
| Korean J Clin Pharm 2022;32(3):215-225 |
|
|
|
Identifying the Patterns of Adverse Drug Responses of Cetuximab
|
| Ji Hyun Park |
| Korean J Clin Pharm 2022;32(3):226-237 |
|
|
|
Impact of ABCB1 C3435T Polymorphism on Treatment Response of Vitamin K Antagonists: A Systematic Review and Meta-analysis
|
| So Yeon Lee and Sook Hee An |
| Korean J Clin Pharm 2022;32(3):238-250 |
|
|
|
Resuscitation Fluids for Patients at High Risk of Multiple Organ Dysfunction Syndromes: A Systematic Review and Meta-analysis
|
| Jae Hyun Nam, Hee Jin Kwack, Woo Seob Ha, and Jee-Eun Chung |
| Korean J Clin Pharm 2022;32(3):251-259 |
|
|
|
Development of Eligibility Criteria for Comprehensive Medication Management Programs in Long-term Care Facilities Using RAND/UCLA Appropriateness Method
|
| Suhyun Jang, Cinoo Kang, Youngmi Ah, Ju-Yeun Lee, Jung-Ha Kim, and Sunmee Jang |
| Korean J Clin Pharm 2022;32(3):260-269 |
|
|
Korean J Clin Pharm 2022;32(3):155-269
